Vitamin K epoxide reductase complex 1 polymorphism and warfarin dose in African Americans.

被引：0
|
作者：
Momary, KM
Nutescu, EA
Shapiro, NL
Viana, MA
Helgason, CM
Cavallari, LH
机构：
[1] Univ Illinois, Coll Pharm, Chicago, IL USA
[2] Univ Illinois, Coll Med, Chicago, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.116
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P32 / P32
页数：1
相关论文
共 50 条
  • [21] Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification - The Rotterdam Study
    Teichert, M.
    Visser, L. E.
    van Schaik, R. H. N.
    Hofman, A.
    Uitterlinden, A. G.
    De Smet, P. A. G. M.
    Witteman, J. C. M.
    Stricker, B. H. Ch.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (04) : 771 - 776
  • [22] Molecular characterization of vitamin K epoxide reductase complex 1 polymorphism in cardiac patients in Shahrekord (Part of Iran)
    Ghorbani-dalini, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0A) : S26 - S27
  • [23] Demographic and environmental influences of warfarin response in African Americans.
    Momary, KM
    Fashingbauer, LA
    Shapiro, NL
    Nutescu, EA
    Helgason, CM
    Pandey, DK
    Cavallari, LH
    PHARMACOTHERAPY, 2004, 24 (10): : 1423 - 1423
  • [24] A vitamin K epoxide reductase-oxidase complex gene polymorphism (−1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists
    E. Stępień
    A. Branicka
    M. Cieśla-Dul
    A Undas
    Journal of Applied Genetics, 2009, 50 : 399 - 403
  • [25] Vitamin K Epoxide Reductase Complex 1 (vkorc1) a New Insight into the Molecular Design, Operation and Mechanism of Warfarin Inhibition
    Wajih, Nadeem
    CIRCULATION, 2011, 124 (21)
  • [26] Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism influences the anticoagulation response subsequent to vitamin K intake:: a pilot study
    Sconce, E. A.
    Avery, P. J.
    Wynne, H. A.
    Kamai, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (07) : 1226 - 1228
  • [27] Structural and functional insights into human vitamin K epoxide reductase and vitamin K epoxide reductase-like 1
    Van Horn, Wade D.
    CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 48 (04) : 357 - 372
  • [28] The effect of NAD(P)H dehydrogenase, quinone 1 genotype on warfarin dose requirements in Hispanic and African Americans.
    Bress, Adam P.
    Patel, Shitalben R.
    Perera, Minoli
    Campbell, Richard T.
    Kittles, Rick
    Cavallari, Larisa H.
    PHARMACOTHERAPY, 2012, 32 (10): : E233 - E233
  • [29] A vitamin K epoxide reductase-oxidise complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists
    Stepien, E.
    Branicka, A.
    Ciesla-Dul, M.
    Undas, A.
    JOURNAL OF APPLIED GENETICS, 2009, 50 (04) : 399 - 403
  • [30] Vitamin K reductase genotype and warfarin dose requirements.
    Momary, K
    Shapiro, NL
    Nutescu, EA
    Helgason, CM
    Cavallari, L
    PHARMACOTHERAPY, 2005, 25 (10): : 1480 - 1480
12345